Shukra Pharmaceuticals Limited (BOM:524632)

Shukra Pharmaceuticals Revenue

Shukra Pharmaceuticals had revenue of 235.22M INR in the quarter ending June 30, 2026, with 336.32% growth. This brings the company's revenue in the last twelve months to 748.59M, up 91.91% year-over-year. In the fiscal year ending March 31, 2026, Shukra Pharmaceuticals had annual revenue of 567.27M with 74.08% growth.

• Revenue (ttm): 748.59M
• Revenue Growth: +91.91%
• P/S Ratio: 24.38
• Revenue / Employee: 6.51M
• Employees: 115
• Market Cap: 18.25B

Revenue Chart

Chart

Chart

Revenue History

Fiscal Year End	Revenue	Change	Growth
Mar 31, 2026	567.27M	241.40M	74.08%
Mar 31, 2025	325.87M	-419.86M	-56.30%
Mar 31, 2024	745.73M	150.80M	25.35%
Mar 31, 2023	594.93M	390.07M	190.41%
Mar 31, 2022	204.86M	92.90M	82.97%

Data Source: S&P Global Market Intelligence Last updated: Jun 30, 2026

Revenue data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Aug 17, 2026

Data Sources Report a data error